Cargando…
Salivary Exosomal miRNA-1307-5p Predicts Disease Aggressiveness and Poor Prognosis in Oral Squamous Cell Carcinoma Patients
Background: Salivary exosomal miRNAs as biomarkers facilitate repeated sampling, real-time disease monitoring and assessment of therapeutic response. This study identifies a single salivary exosomal miRNA prognosticator that will aid in improved patient outcome using a liquid biopsy approach. Method...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505291/ https://www.ncbi.nlm.nih.gov/pubmed/36142544 http://dx.doi.org/10.3390/ijms231810639 |
_version_ | 1784796435772866560 |
---|---|
author | Patel, Aditi Patel, Shanaya Patel, Parina Mandlik, Dushyant Patel, Kaustubh Tanavde, Vivek |
author_facet | Patel, Aditi Patel, Shanaya Patel, Parina Mandlik, Dushyant Patel, Kaustubh Tanavde, Vivek |
author_sort | Patel, Aditi |
collection | PubMed |
description | Background: Salivary exosomal miRNAs as biomarkers facilitate repeated sampling, real-time disease monitoring and assessment of therapeutic response. This study identifies a single salivary exosomal miRNA prognosticator that will aid in improved patient outcome using a liquid biopsy approach. Method: Small RNA and transcriptome sequencing profiles of tumour tissues (n = 12) and salivary exosomes (n = 8) from oral cancer patients were compared to their non-cancerous counterparts. We validated these results using The Cancer Genome Atlas database and performing Real-time PCR on a large patient cohort (n = 19 tissue samples; n = 12 salivary exosomes). Potential target genes and the miRNA–mRNA networks and enriched biological pathways regulated by this microRNA were identified using computational tools. Results: Salivary exosomes (size: 30–50 nm) demonstrated a strong expression of CD47 and detectable expression of tetraspanins CD63, CD81 and CD9 by flow cytometry. miR-1307-5p was exclusively overexpressed in tissues and salivary exosomes of oral cancer patients compared to their non-cancerous counterparts. Enhanced expression of miR-1307-5p clinically correlated with poor patient survival, disease progression, aggressiveness and chemo-resistance. Transcriptome analysis suggested that miRNA-1307-5p could promote oral cancer progression by suppressing THOP1, EHF, RNF4, GET4 and RNF114. Conclusions: Salivary exosomal miRNA-1307-5p is a potential prognosticator for predicting poor survival and poor patient outcome in oral cancers. |
format | Online Article Text |
id | pubmed-9505291 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2022 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-95052912022-09-24 Salivary Exosomal miRNA-1307-5p Predicts Disease Aggressiveness and Poor Prognosis in Oral Squamous Cell Carcinoma Patients Patel, Aditi Patel, Shanaya Patel, Parina Mandlik, Dushyant Patel, Kaustubh Tanavde, Vivek Int J Mol Sci Article Background: Salivary exosomal miRNAs as biomarkers facilitate repeated sampling, real-time disease monitoring and assessment of therapeutic response. This study identifies a single salivary exosomal miRNA prognosticator that will aid in improved patient outcome using a liquid biopsy approach. Method: Small RNA and transcriptome sequencing profiles of tumour tissues (n = 12) and salivary exosomes (n = 8) from oral cancer patients were compared to their non-cancerous counterparts. We validated these results using The Cancer Genome Atlas database and performing Real-time PCR on a large patient cohort (n = 19 tissue samples; n = 12 salivary exosomes). Potential target genes and the miRNA–mRNA networks and enriched biological pathways regulated by this microRNA were identified using computational tools. Results: Salivary exosomes (size: 30–50 nm) demonstrated a strong expression of CD47 and detectable expression of tetraspanins CD63, CD81 and CD9 by flow cytometry. miR-1307-5p was exclusively overexpressed in tissues and salivary exosomes of oral cancer patients compared to their non-cancerous counterparts. Enhanced expression of miR-1307-5p clinically correlated with poor patient survival, disease progression, aggressiveness and chemo-resistance. Transcriptome analysis suggested that miRNA-1307-5p could promote oral cancer progression by suppressing THOP1, EHF, RNF4, GET4 and RNF114. Conclusions: Salivary exosomal miRNA-1307-5p is a potential prognosticator for predicting poor survival and poor patient outcome in oral cancers. MDPI 2022-09-13 /pmc/articles/PMC9505291/ /pubmed/36142544 http://dx.doi.org/10.3390/ijms231810639 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Patel, Aditi Patel, Shanaya Patel, Parina Mandlik, Dushyant Patel, Kaustubh Tanavde, Vivek Salivary Exosomal miRNA-1307-5p Predicts Disease Aggressiveness and Poor Prognosis in Oral Squamous Cell Carcinoma Patients |
title | Salivary Exosomal miRNA-1307-5p Predicts Disease Aggressiveness and Poor Prognosis in Oral Squamous Cell Carcinoma Patients |
title_full | Salivary Exosomal miRNA-1307-5p Predicts Disease Aggressiveness and Poor Prognosis in Oral Squamous Cell Carcinoma Patients |
title_fullStr | Salivary Exosomal miRNA-1307-5p Predicts Disease Aggressiveness and Poor Prognosis in Oral Squamous Cell Carcinoma Patients |
title_full_unstemmed | Salivary Exosomal miRNA-1307-5p Predicts Disease Aggressiveness and Poor Prognosis in Oral Squamous Cell Carcinoma Patients |
title_short | Salivary Exosomal miRNA-1307-5p Predicts Disease Aggressiveness and Poor Prognosis in Oral Squamous Cell Carcinoma Patients |
title_sort | salivary exosomal mirna-1307-5p predicts disease aggressiveness and poor prognosis in oral squamous cell carcinoma patients |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9505291/ https://www.ncbi.nlm.nih.gov/pubmed/36142544 http://dx.doi.org/10.3390/ijms231810639 |
work_keys_str_mv | AT pateladiti salivaryexosomalmirna13075ppredictsdiseaseaggressivenessandpoorprognosisinoralsquamouscellcarcinomapatients AT patelshanaya salivaryexosomalmirna13075ppredictsdiseaseaggressivenessandpoorprognosisinoralsquamouscellcarcinomapatients AT patelparina salivaryexosomalmirna13075ppredictsdiseaseaggressivenessandpoorprognosisinoralsquamouscellcarcinomapatients AT mandlikdushyant salivaryexosomalmirna13075ppredictsdiseaseaggressivenessandpoorprognosisinoralsquamouscellcarcinomapatients AT patelkaustubh salivaryexosomalmirna13075ppredictsdiseaseaggressivenessandpoorprognosisinoralsquamouscellcarcinomapatients AT tanavdevivek salivaryexosomalmirna13075ppredictsdiseaseaggressivenessandpoorprognosisinoralsquamouscellcarcinomapatients |